|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2003-10-30
|
|
pubmed:abstractText |
Multiple treatment guidelines for non-steroidal anti-inflammatory drugs (NSAIDs) suggest that patients with one or more risk factors for NSAID-associated upper gastrointestinal (UGI) ulcer complications should be prescribed preventive strategies such as acid-suppressive drugs, misoprostol or cyclooxygenase (COX)-2-specific inhibitors to reduce their risk of serious ulcer complications. The purpose of the present study was to evaluate the extent to which new NSAID users receive recommended preventive strategies and to assess the association between risk factors and a prescription of acid suppressive drugs or misoprostol.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antacids,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Lactones,
http://linkedlifedata.com/resource/pubmed/chemical/Misoprostol,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfones,
http://linkedlifedata.com/resource/pubmed/chemical/celecoxib,
http://linkedlifedata.com/resource/pubmed/chemical/rofecoxib
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1462-0324
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42 Suppl 3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
iii23-31
|
|
pubmed:dateRevised |
2007-9-6
|
|
pubmed:meshHeading |
pubmed-meshheading:14585915-Adult,
pubmed-meshheading:14585915-Aged,
pubmed-meshheading:14585915-Antacids,
pubmed-meshheading:14585915-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:14585915-Anti-Ulcer Agents,
pubmed-meshheading:14585915-Cohort Studies,
pubmed-meshheading:14585915-Cyclooxygenase Inhibitors,
pubmed-meshheading:14585915-Drug Utilization,
pubmed-meshheading:14585915-Female,
pubmed-meshheading:14585915-Humans,
pubmed-meshheading:14585915-Lactones,
pubmed-meshheading:14585915-Male,
pubmed-meshheading:14585915-Middle Aged,
pubmed-meshheading:14585915-Misoprostol,
pubmed-meshheading:14585915-Netherlands,
pubmed-meshheading:14585915-Peptic Ulcer,
pubmed-meshheading:14585915-Prognosis,
pubmed-meshheading:14585915-Pyrazoles,
pubmed-meshheading:14585915-Referral and Consultation,
pubmed-meshheading:14585915-Retrospective Studies,
pubmed-meshheading:14585915-Risk Factors,
pubmed-meshheading:14585915-Sulfonamides,
pubmed-meshheading:14585915-Sulfones
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Underutilization of preventive strategies in patients receiving NSAIDs.
|
|
pubmed:affiliation |
Department of Epidemiology & Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands. m.sturkenboom@erasmusmc.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
